The Antidepressant Metapramine is a Low-affinity Antagonist at N-methyl-d-aspartic Acid Receptors
- 31 December 1996
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 35 (12), 1703-1707
- https://doi.org/10.1016/s0028-3908(96)00122-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- MonthlyUpdate—Central & Peripheral Nervous Systems: Pharmacotherapeutic Potential for Compounds Acting at NMDA Receptors: Update 1995Expert Opinion on Investigational Drugs, 1995
- Clinical Experience With Excitatory Amino Acid Antagonist DrugsStroke, 1995
- Therapeutic potential of PCP receptor ligandsExpert Opinion on Investigational Drugs, 1994
- NMDA receptors: the first decadeExpert Opinion on Investigational Drugs, 1994
- The NMDA receptor complexFundamental & Clinical Pharmacology, 1993
- Modulation of Mg2+-dependent [3H]TCP binding byL-glutamate, glycine, and guanine nucleotides in rat cerebral cortexSynapse, 1991
- The Glycine Site of the N‐Methyl‐D‐Aspartate Receptor Channel: Differences Between the Binding of HA‐966 and of 7‐Chlorokynurenic AcidJournal of Neurochemistry, 1990
- Cooperative Modulation of [3H]MK‐801 Binding to the N‐Methyl‐d‐Aspartate Receptor‐Ion Channel Complex by l‐Glutamate, Glycine, and PolyaminesJournal of Neurochemistry, 1988
- Zinc Selectively Blocks the Action of N -Methyl-D-Aspartate on Cortical NeuronsScience, 1987
- Glutamate: A Neurotransmitter in Mammalian BrainJournal of Neurochemistry, 1984